These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 26886104
1. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders. Yamamoto T, Tateno F, Sakakibara R, Furukawa S, Asahina M, Uchiyama T, Hirano S, Yamanaka Y, Fuse M, Koga Y, Yanagisawa M, Kuwabara S. PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104 [Abstract] [Full Text] [Related]
2. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy. Kim KJ, Jeong SJ, Kim JM. Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135 [Abstract] [Full Text] [Related]
3. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy. Malkiewicz JJ, Siuda J. Neurol Neurochir Pol; 2024 Jun; 58(2):193-202. PubMed ID: 38148738 [Abstract] [Full Text] [Related]
4. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Yoshita M, Hayashi M, Hirai S. Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173 [Abstract] [Full Text] [Related]
5. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Gilman S, Koeppe RA, Nan B, Wang CN, Wang X, Junck L, Chervin RD, Consens F, Bhaumik A. Neurology; 2010 May 04; 74(18):1416-23. PubMed ID: 20439843 [Abstract] [Full Text] [Related]
6. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R. J Neural Transm (Vienna); 2016 Dec 04; 123(12):1435-1442. PubMed ID: 27334897 [Abstract] [Full Text] [Related]
7. Urinary Dysfunctions and Post-Void Residual Urine in Typical and Atypical Parkinson Diseases. Lee YH, Lee JE, Ryu DW, Oh YS, Lee KS, Hong SH, Kim JS. J Parkinsons Dis; 2018 Dec 04; 8(1):145-152. PubMed ID: 29480228 [Abstract] [Full Text] [Related]
9. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease. Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R. J Neural Transm (Vienna); 2019 Nov 04; 126(11):1437-1445. PubMed ID: 31432258 [Abstract] [Full Text] [Related]
10. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M. J Neurol; 2018 Nov 04; 265(11):2602-2613. PubMed ID: 30178175 [Abstract] [Full Text] [Related]
11. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease. Kass-Iliyya L, Kobylecki C, McDonald KR, Gerhard A, Silverdale MA. Brain Behav; 2015 May 04; 5(5):e00320. PubMed ID: 25874161 [Abstract] [Full Text] [Related]
12. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy. Jia P, Zhang J, Han J, Ji Y. Brain Behav; 2022 Dec 04; 12(12):e2827. PubMed ID: 36409061 [Abstract] [Full Text] [Related]
13. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. De Pablo-Fernández E, Courtney R, Warner TT, Holton JL. JAMA Neurol; 2018 Aug 01; 75(8):1008-1012. PubMed ID: 29710120 [Abstract] [Full Text] [Related]
14. Serum uric acid levels in Parkinson's disease and related disorders. Sakuta H, Suzuki K, Miyamoto T, Miyamoto M, Numao A, Fujita H, Watanabe Y, Hirata K. Brain Behav; 2017 Jan 01; 7(1):e00598. PubMed ID: 28127516 [Abstract] [Full Text] [Related]
15. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. Yamamoto T, Asahina M, Yamanaka Y, Uchiyama T, Hirano S, Fuse M, Koga Y, Sakakibara R, Kuwabara S. J Neurol Sci; 2017 Oct 15; 381():230-234. PubMed ID: 28991688 [Abstract] [Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Paviour DC, Thornton JS, Lees AJ, Jäger HR. Mov Disord; 2007 Jan 15; 22(1):68-74. PubMed ID: 17089396 [Abstract] [Full Text] [Related]
17. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation. Murthy M, Fodder K, Miki Y, Rambarack N, De Pablo Fernandez E, Pihlstrøm L, Mill J, Warner TT, Lashley T, Bettencourt C. Acta Neuropathol; 2024 Jul 12; 148(1):4. PubMed ID: 38995454 [Abstract] [Full Text] [Related]
18. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH. J Neurol Sci; 2013 Feb 15; 325(1-2):29-35. PubMed ID: 23260321 [Abstract] [Full Text] [Related]
19. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T. Parkinsonism Relat Disord; 2013 Dec 15; 19(12):1149-51. PubMed ID: 23916652 [Abstract] [Full Text] [Related]
20. The interrelationship between non-motor symptoms in Atypical Parkinsonism. Lee CN, Kim M, Lee HM, Jang JW, Lee SM, Kwon DY, Park KW, Koh SB. J Neurol Sci; 2013 Apr 15; 327(1-2):15-21. PubMed ID: 23428208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]